Sequencing Studies Demonstrate Scope of Genetic Information Accessible in Circulating Tumor DNA | GenomeWeb

Studies published by two independent research teams this past week are extending the scope of sequencing-based analyses applied to cell-free tumor DNA circulating in cancer patients' blood.

Together, the proof-of-principle studies point to the circulating tumor DNA both as a source of information for cataloging the genes and pathways involved in treatment resistance or relapse and as a source of information on metastatic disease in a clinical setting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.